Learn More
Cayman Chemical GInsenosIde Rg1 25mg

Supplier: Cayman Chemical 1531525 MG
A steroid glycoside with diverse biological activities; decreases blood glucose, IL-1β, and IL-18 levels, increases insulin secretion, and inhibits hepatic and pancreatic activation of the NLRP3 inflammasome in a mouse model of STZ-induced diabetes at 10, 20, and 40 mg/kg; facilitates fear extinction and decreases immobility time in the tail-suspension and forced swim tests in a mouse model of single-prolonged stress-induced PTSD; decreases hepatic ALT and AST levels and attenuates hepatic steatosis in a mouse model of ethanol-induced hepatitis; decreases the abundance of Bacteroidetes in the large intestine, cortical neuron apoptosis, and latency to the platform in the Morris water maze in a tree shrew model of Aβ (25-35)-induced Alzheimer’s disease
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.